{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 319,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 320,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Primary_Site</th>\n",
       "      <th>Protocol</th>\n",
       "      <th>Principal_Investigator</th>\n",
       "      <th>Date_Opened</th>\n",
       "      <th>Date_Closed</th>\n",
       "      <th>Study_Phase</th>\n",
       "      <th>Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Brain and Nervous System</td>\n",
       "      <td>N-1262421</td>\n",
       "      <td>Abad, A</td>\n",
       "      <td>01/07/2022</td>\n",
       "      <td>NaN</td>\n",
       "      <td>II</td>\n",
       "      <td>(A071702) A Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent WHO Grade 4 Glioma</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "               Primary_Site   Protocol Principal_Investigator Date_Opened  \\\n",
       "0  Brain and Nervous System  N-1262421                Abad, A  01/07/2022   \n",
       "\n",
       "  Date_Closed Study_Phase  \\\n",
       "0         NaN          II   \n",
       "\n",
       "                                                                                                                                    Title  \n",
       "0  (A071702) A Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent WHO Grade 4 Glioma  "
      ]
     },
     "execution_count": 320,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials = pd.read_csv('Current_Active_Clinical_Trials_-_Roswell_Park_Cancer_Institute.csv')\n",
    "df_trials.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 321,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Primary_Site</th>\n",
       "      <th>Protocol</th>\n",
       "      <th>Principal_Investigator</th>\n",
       "      <th>Date_Opened</th>\n",
       "      <th>Date_Closed</th>\n",
       "      <th>Study_Phase</th>\n",
       "      <th>Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Brain and Nervous System</td>\n",
       "      <td>N-1262421</td>\n",
       "      <td>Abad, A</td>\n",
       "      <td>01/07/2022</td>\n",
       "      <td>NaN</td>\n",
       "      <td>II</td>\n",
       "      <td>(A071702) A Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent WHO Grade 4 Glioma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Brain and Nervous System</td>\n",
       "      <td>I-546319</td>\n",
       "      <td>Abad, A</td>\n",
       "      <td>07/08/2021</td>\n",
       "      <td>03/23/2022</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Expanded Access to SurVaxM for Treatment of Patients with Glioblastoma Who Have No Access to Other Comparable or Alternative Therapy or Have Completed Treatment on a non-Randomized Clinical Trial of SurVaxM and May Benefit from Further Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Brain and Nervous System</td>\n",
       "      <td>P-1281721</td>\n",
       "      <td>Abad, A</td>\n",
       "      <td>03/08/2022</td>\n",
       "      <td>NaN</td>\n",
       "      <td>II</td>\n",
       "      <td>A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Brain and Nervous System</td>\n",
       "      <td>I-813720</td>\n",
       "      <td>Abad, A</td>\n",
       "      <td>12/29/2021</td>\n",
       "      <td>NaN</td>\n",
       "      <td>II</td>\n",
       "      <td>Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "               Primary_Site   Protocol Principal_Investigator Date_Opened  \\\n",
       "0  Brain and Nervous System  N-1262421                Abad, A  01/07/2022   \n",
       "1  Brain and Nervous System   I-546319                Abad, A  07/08/2021   \n",
       "2  Brain and Nervous System  P-1281721                Abad, A  03/08/2022   \n",
       "3  Brain and Nervous System   I-813720                Abad, A  12/29/2021   \n",
       "\n",
       "  Date_Closed Study_Phase  \\\n",
       "0         NaN          II   \n",
       "1  03/23/2022         NaN   \n",
       "2         NaN          II   \n",
       "3         NaN          II   \n",
       "\n",
       "                                                                                                                                                                                                                                                                 Title  \n",
       "0                                                                                                                               (A071702) A Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent WHO Grade 4 Glioma  \n",
       "1                Expanded Access to SurVaxM for Treatment of Patients with Glioblastoma Who Have No Access to Other Comparable or Alternative Therapy or Have Completed Treatment on a non-Randomized Clinical Trial of SurVaxM and May Benefit from Further Treatment  \n",
       "2  A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy  \n",
       "3                                                                                                                                     Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)  "
      ]
     },
     "execution_count": 321,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials[df_trials['Principal_Investigator'] == 'Abad, A' ]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 322,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_trials['Principal_Investigator'] = df_trials['Principal_Investigator'].str.strip()\n",
    "df_trials['Principal_Investigator'] = df_trials['Principal_Investigator'].str.lower()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 323,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['abad, a', 'alarcon velasco, s', 'aly, a', 'ambrosone, c',\n",
       "       'bain, a', 'bambach, b', 'barth, m', 'besharat shafiei, s',\n",
       "       'bonaccio, e', 'bouchard, e', 'buxbaum, n', 'chatta, g', 'chen, g',\n",
       "       'chen, h', 'chowdhry, v', 'cortese, m', 'dean, g', 'demmy, t',\n",
       "       'dexter, e', 'dy, g', 'fabiano, a', 'fenstermaker, r',\n",
       "       'fountzilas, c', 'frederick, p', 'fung-kee-fung, s', 'gandhi, s',\n",
       "       'george, s', 'ghione, p', 'glaser, k', 'goniewicz, m',\n",
       "       'gopalakrishnan, d', 'green, s', 'griffiths, e', 'grimmer, j',\n",
       "       'gupta, a', 'guru, k', 'hahn, t', 'haring, r', 'hernandez, f',\n",
       "       'herr, m', 'hicks, w', 'hillengass, j', 'hiscock, m', 'ho, c',\n",
       "       'hong, c', 'hutson, a', 'hyland, a', 'ivanick, n', 'iyer, r',\n",
       "       'jain, p', 'kane, j', 'kelly, k', 'keppel, a', 'kisailus, a',\n",
       "       'krishnamurthy, a', 'kuettel, m', 'kukar, m', 'lau, j', 'lee, k',\n",
       "       'lele, s', 'levine, e', 'lipinski, l', 'mahoney, m', 'malik, n',\n",
       "       'mccarthy, p', 'mcspadden, r', 'mohler, j', 'morrison, c',\n",
       "       'moysich, k', 'mukherjee, s', 'nastiuk, k', 'nwogu, c',\n",
       "       \"o'brien, s\", \"o'connor, r\", \"o'connor, t\", 'odunsi, k',\n",
       "       'ozturk, c', 'paragh, g', 'pokharel, s', 'prasad, d',\n",
       "       'przespolewski, a', 'puzanov, i', 'quinn, t', 'quisenberry, a',\n",
       "       'reid, m', 'riebandt, g', 'rodriguez, e', 'rokitka, d', 'ross, m',\n",
       "       'schneller, l', 'segal, b', 'sheffer, c', 'sherrow, c', 'singh, a',\n",
       "       'skitzki, j', 'smith, d', 'storer, a', 'sumlin, a', 'thompson, j',\n",
       "       'torka, p', 'travers, m', 'twist, c', 'vadehra, d', 'walter, m',\n",
       "       'wang, e', 'witkiewicz, a', 'wooten, k', 'yau, e', 'yeary, k',\n",
       "       'yendamuri, s', 'zsiros, e'], dtype=object)"
      ]
     },
     "execution_count": 323,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials['Principal_Investigator'].unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 324,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Principal_Investigator</th>\n",
       "      <th>Primary_Site</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>abad, a</td>\n",
       "      <td>Brain and Nervous System</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>alarcon velasco, s</td>\n",
       "      <td>Colon</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>aly, a</td>\n",
       "      <td>Bladder, Prostate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ambrosone, c</td>\n",
       "      <td>Breast</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>bain, a</td>\n",
       "      <td>Pancreas</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>wooten, k</td>\n",
       "      <td>Lip, Oral Cavity and Pharynx, Melanoma, Skin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>yau, e</td>\n",
       "      <td>Lung</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>yeary, k</td>\n",
       "      <td>Bladder, nan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>yendamuri, s</td>\n",
       "      <td>Multiple Sites, Lung, nan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>zsiros, e</td>\n",
       "      <td>Multiple Sites, Multiple, Cervix Uteri, Ovary, Corpus Uteri; Ovary, Unknown Sites</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>111 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Principal_Investigator  \\\n",
       "0                  abad, a   \n",
       "1       alarcon velasco, s   \n",
       "2                   aly, a   \n",
       "3             ambrosone, c   \n",
       "4                  bain, a   \n",
       "..                     ...   \n",
       "106              wooten, k   \n",
       "107                 yau, e   \n",
       "108               yeary, k   \n",
       "109           yendamuri, s   \n",
       "110              zsiros, e   \n",
       "\n",
       "                                                                          Primary_Site  \n",
       "0                                                             Brain and Nervous System  \n",
       "1                                                                                Colon  \n",
       "2                                                                    Bladder, Prostate  \n",
       "3                                                                               Breast  \n",
       "4                                                                             Pancreas  \n",
       "..                                                                                 ...  \n",
       "106                                       Lip, Oral Cavity and Pharynx, Melanoma, Skin  \n",
       "107                                                                               Lung  \n",
       "108                                                                       Bladder, nan  \n",
       "109                                                          Multiple Sites, Lung, nan  \n",
       "110  Multiple Sites, Multiple, Cervix Uteri, Ovary, Corpus Uteri; Ovary, Unknown Sites  \n",
       "\n",
       "[111 rows x 2 columns]"
      ]
     },
     "execution_count": 324,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials.groupby('Principal_Investigator')['Primary_Site'].apply(lambda x: ', '.join(x.astype(str).unique())).reset_index()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 325,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 463 entries, 0 to 462\n",
      "Data columns (total 7 columns):\n",
      " #   Column                  Non-Null Count  Dtype \n",
      "---  ------                  --------------  ----- \n",
      " 0   Primary_Site            424 non-null    object\n",
      " 1   Protocol                463 non-null    object\n",
      " 2   Principal_Investigator  463 non-null    object\n",
      " 3   Date_Opened             462 non-null    object\n",
      " 4   Date_Closed             163 non-null    object\n",
      " 5   Study_Phase             291 non-null    object\n",
      " 6   Title                   463 non-null    object\n",
      "dtypes: object(7)\n",
      "memory usage: 25.4+ KB\n"
     ]
    }
   ],
   "source": [
    "df_trials.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 326,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_trials['Date_Opened'] = pd.to_datetime(df_trials['Date_Opened'],format='%m/%d/%Y')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 327,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_trials['Date_Closed'] = pd.to_datetime(df_trials['Date_Closed'],format='%m/%d/%Y')\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 328,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Primary_Site</th>\n",
       "      <th>Protocol</th>\n",
       "      <th>Principal_Investigator</th>\n",
       "      <th>Date_Opened</th>\n",
       "      <th>Date_Closed</th>\n",
       "      <th>Study_Phase</th>\n",
       "      <th>Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Brain and Nervous System</td>\n",
       "      <td>N-1262421</td>\n",
       "      <td>abad, a</td>\n",
       "      <td>2022-01-07</td>\n",
       "      <td>NaT</td>\n",
       "      <td>II</td>\n",
       "      <td>(A071702) A Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent WHO Grade 4 Glioma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Brain and Nervous System</td>\n",
       "      <td>I-546319</td>\n",
       "      <td>abad, a</td>\n",
       "      <td>2021-07-08</td>\n",
       "      <td>2022-03-23</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Expanded Access to SurVaxM for Treatment of Patients with Glioblastoma Who Have No Access to Other Comparable or Alternative Therapy or Have Completed Treatment on a non-Randomized Clinical Trial of SurVaxM and May Benefit from Further Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Brain and Nervous System</td>\n",
       "      <td>P-1281721</td>\n",
       "      <td>abad, a</td>\n",
       "      <td>2022-03-08</td>\n",
       "      <td>NaT</td>\n",
       "      <td>II</td>\n",
       "      <td>A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Brain and Nervous System</td>\n",
       "      <td>I-813720</td>\n",
       "      <td>abad, a</td>\n",
       "      <td>2021-12-29</td>\n",
       "      <td>NaT</td>\n",
       "      <td>II</td>\n",
       "      <td>Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Colon</td>\n",
       "      <td>N-626620</td>\n",
       "      <td>alarcon velasco, s</td>\n",
       "      <td>2020-07-15</td>\n",
       "      <td>2023-02-27</td>\n",
       "      <td>II</td>\n",
       "      <td>(S1922) A Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>458</th>\n",
       "      <td>Multiple</td>\n",
       "      <td>P-1391721</td>\n",
       "      <td>zsiros, e</td>\n",
       "      <td>2022-05-20</td>\n",
       "      <td>NaT</td>\n",
       "      <td>I/II</td>\n",
       "      <td>NC762-01 A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of NC762 in Subjects with Advanced or Metastatic Solid Tumors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>459</th>\n",
       "      <td>Multiple</td>\n",
       "      <td>P-2058021</td>\n",
       "      <td>zsiros, e</td>\n",
       "      <td>2022-07-29</td>\n",
       "      <td>NaT</td>\n",
       "      <td>I</td>\n",
       "      <td>A Phase 1 Safety and Tolerability Study of DeTIL-0255 in Adults with Advanced Malignancies</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>460</th>\n",
       "      <td>Multiple</td>\n",
       "      <td>P-1263921</td>\n",
       "      <td>zsiros, e</td>\n",
       "      <td>2022-02-18</td>\n",
       "      <td>2022-12-07</td>\n",
       "      <td>I</td>\n",
       "      <td>A Phase 1, multicenter, Open-Label Study of SQZ-AAC-HPV as Monotherapy and in Combination with Immune Checkpoint Inhibitors in HLA-A*02+ Patients with HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>461</th>\n",
       "      <td>Corpus Uteri; Ovary</td>\n",
       "      <td>I-37616</td>\n",
       "      <td>zsiros, e</td>\n",
       "      <td>2016-12-12</td>\n",
       "      <td>NaT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Life On The Go 1: Evaluating the Effect of Baseline Physical Activity of Patients with Endometrial and Ovarian Cancer using State of the Art Activity Tracking Device</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>462</th>\n",
       "      <td>Unknown Sites</td>\n",
       "      <td>I-56117</td>\n",
       "      <td>zsiros, e</td>\n",
       "      <td>2018-06-13</td>\n",
       "      <td>2022-12-14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The GYN Molecular Information Registry</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>463 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                 Primary_Site   Protocol Principal_Investigator Date_Opened  \\\n",
       "0    Brain and Nervous System  N-1262421                abad, a  2022-01-07   \n",
       "1    Brain and Nervous System   I-546319                abad, a  2021-07-08   \n",
       "2    Brain and Nervous System  P-1281721                abad, a  2022-03-08   \n",
       "3    Brain and Nervous System   I-813720                abad, a  2021-12-29   \n",
       "4                       Colon   N-626620     alarcon velasco, s  2020-07-15   \n",
       "..                        ...        ...                    ...         ...   \n",
       "458                  Multiple  P-1391721              zsiros, e  2022-05-20   \n",
       "459                  Multiple  P-2058021              zsiros, e  2022-07-29   \n",
       "460                  Multiple  P-1263921              zsiros, e  2022-02-18   \n",
       "461       Corpus Uteri; Ovary    I-37616              zsiros, e  2016-12-12   \n",
       "462             Unknown Sites    I-56117              zsiros, e  2018-06-13   \n",
       "\n",
       "    Date_Closed Study_Phase  \\\n",
       "0           NaT          II   \n",
       "1    2022-03-23         NaN   \n",
       "2           NaT          II   \n",
       "3           NaT          II   \n",
       "4    2023-02-27          II   \n",
       "..          ...         ...   \n",
       "458         NaT        I/II   \n",
       "459         NaT           I   \n",
       "460  2022-12-07           I   \n",
       "461         NaT         NaN   \n",
       "462  2022-12-14         NaN   \n",
       "\n",
       "                                                                                                                                                                                                                                                                   Title  \n",
       "0                                                                                                                                 (A071702) A Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent WHO Grade 4 Glioma  \n",
       "1                  Expanded Access to SurVaxM for Treatment of Patients with Glioblastoma Who Have No Access to Other Comparable or Alternative Therapy or Have Completed Treatment on a non-Randomized Clinical Trial of SurVaxM and May Benefit from Further Treatment  \n",
       "2    A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy  \n",
       "3                                                                                                                                       Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)  \n",
       "4                                                                                                                                    (S1922) A Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma  \n",
       "..                                                                                                                                                                                                                                                                   ...  \n",
       "458                                                                                                                       NC762-01 A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of NC762 in Subjects with Advanced or Metastatic Solid Tumors  \n",
       "459                                                                                                                                                                           A Phase 1 Safety and Tolerability Study of DeTIL-0255 in Adults with Advanced Malignancies  \n",
       "460                                                 A Phase 1, multicenter, Open-Label Study of SQZ-AAC-HPV as Monotherapy and in Combination with Immune Checkpoint Inhibitors in HLA-A*02+ Patients with HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors  \n",
       "461                                                                                                Life On The Go 1: Evaluating the Effect of Baseline Physical Activity of Patients with Endometrial and Ovarian Cancer using State of the Art Activity Tracking Device  \n",
       "462                                                                                                                                                                                                                               The GYN Molecular Information Registry  \n",
       "\n",
       "[463 rows x 7 columns]"
      ]
     },
     "execution_count": 328,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 329,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Primary_Site', 'Protocol', 'Principal_Investigator', 'Date_Opened',\n",
       "       'Date_Closed', 'Study_Phase', 'Title'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 329,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 330,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "62"
      ]
     },
     "execution_count": 330,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials['Primary_Site'].nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 331,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_trials = df_trials.dropna(subset=['Date_Closed'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 332,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_trials = df_trials.dropna(subset=['Study_Phase'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 333,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Primary_Site              5\n",
       "Protocol                  0\n",
       "Principal_Investigator    0\n",
       "Date_Opened               0\n",
       "Date_Closed               0\n",
       "Study_Phase               0\n",
       "Title                     0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 333,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials.isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 334,
   "metadata": {},
   "outputs": [],
   "source": [
    "nan_rows_primary = df_trials[df_trials['Primary_Site'].isna()]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 335,
   "metadata": {},
   "outputs": [],
   "source": [
    "# DRop de la variable\n",
    "\n",
    "df_trials = df_trials.drop(nan_rows_primary.index)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 336,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Primary_Site</th>\n",
       "      <th>Protocol</th>\n",
       "      <th>Principal_Investigator</th>\n",
       "      <th>Date_Opened</th>\n",
       "      <th>Date_Closed</th>\n",
       "      <th>Study_Phase</th>\n",
       "      <th>Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Colon</td>\n",
       "      <td>N-626620</td>\n",
       "      <td>alarcon velasco, s</td>\n",
       "      <td>2020-07-15</td>\n",
       "      <td>2023-02-27</td>\n",
       "      <td>II</td>\n",
       "      <td>(S1922) A Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Other Hematopoietic</td>\n",
       "      <td>N-71918</td>\n",
       "      <td>bambach, b</td>\n",
       "      <td>2018-10-11</td>\n",
       "      <td>2022-04-15</td>\n",
       "      <td>III</td>\n",
       "      <td>(ACCL1633) The Effectiveness of Lactobacillus plantarum (LBP, IND# 17339) in Preventing Acute Graft-versus-Host Disease (GvHD) in Children undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Multiple Sites; Leukemia, other</td>\n",
       "      <td>PH-271115</td>\n",
       "      <td>bambach, b</td>\n",
       "      <td>2016-08-03</td>\n",
       "      <td>2021-06-10</td>\n",
       "      <td>III</td>\n",
       "      <td>(ACCL1333/CV185-155) A Phase III Randomized, Open Label, Multi-center Study of the Safety and Efficacy of Apixaban for Venous Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (T or B cell) Treated with Asparaginase</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Multiple Sites; Bladder</td>\n",
       "      <td>I-69518</td>\n",
       "      <td>chatta, g</td>\n",
       "      <td>2019-04-10</td>\n",
       "      <td>2022-12-01</td>\n",
       "      <td>II</td>\n",
       "      <td>(CITN-14) Randomized Phase II study of Atezolizumab (MPDL3280A) plus Recombinant Human IL-7 (CYT107) in patients with locally advanced or metastatic urothelial carcinoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Prostate</td>\n",
       "      <td>I-63418</td>\n",
       "      <td>chatta, g</td>\n",
       "      <td>2019-06-07</td>\n",
       "      <td>2022-07-20</td>\n",
       "      <td>I/II</td>\n",
       "      <td>Phase Ib/II Study of Enzalutamide with Venetoclax (ABT-199) in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>432</th>\n",
       "      <td>Myeloid and Monocytic Leukemia</td>\n",
       "      <td>P-1187721</td>\n",
       "      <td>wang, e</td>\n",
       "      <td>2022-05-25</td>\n",
       "      <td>2022-10-25</td>\n",
       "      <td>II</td>\n",
       "      <td>A Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients with Myeloid Malignancies</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>434</th>\n",
       "      <td>Myeloid and Monocytic Leukemia</td>\n",
       "      <td>P-57117</td>\n",
       "      <td>wang, e</td>\n",
       "      <td>2018-07-11</td>\n",
       "      <td>2022-09-19</td>\n",
       "      <td>I</td>\n",
       "      <td>A Phase 1/2, Multi-center, Open-label Study of IMGN632 Monotherapy Administered Intravenously in Patients with CD123-positive Acute Myeloid Leukemia and Other CD123- positive Hematologic Malignancies</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>438</th>\n",
       "      <td>Myeloid and Monocytic Leukemia; Leukemia, other</td>\n",
       "      <td>P-46617</td>\n",
       "      <td>wang, e</td>\n",
       "      <td>2018-01-10</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>I/II</td>\n",
       "      <td>Tagraxofusp (SL-401) in Patients with Chronic Myelomonocytic Leukemia (CMML) or Myelofibrosis (MF)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>455</th>\n",
       "      <td>Multiple</td>\n",
       "      <td>P-762420</td>\n",
       "      <td>zsiros, e</td>\n",
       "      <td>2022-03-17</td>\n",
       "      <td>2022-08-19</td>\n",
       "      <td>I</td>\n",
       "      <td>20190131 A Phase 1, Multicenter, Open-label,Dose-Exploration and Dose-Expansion Study Evaluating the Safety,Tolerability,Pharmacokinetics, and Efficacy of AMG 650 in Subjects With Advanced Solid Tumors</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>460</th>\n",
       "      <td>Multiple</td>\n",
       "      <td>P-1263921</td>\n",
       "      <td>zsiros, e</td>\n",
       "      <td>2022-02-18</td>\n",
       "      <td>2022-12-07</td>\n",
       "      <td>I</td>\n",
       "      <td>A Phase 1, multicenter, Open-Label Study of SQZ-AAC-HPV as Monotherapy and in Combination with Immune Checkpoint Inhibitors in HLA-A*02+ Patients with HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>105 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        Primary_Site   Protocol  \\\n",
       "4                                              Colon   N-626620   \n",
       "10                               Other Hematopoietic    N-71918   \n",
       "11                   Multiple Sites; Leukemia, other  PH-271115   \n",
       "30                           Multiple Sites; Bladder    I-69518   \n",
       "31                                          Prostate    I-63418   \n",
       "..                                               ...        ...   \n",
       "432                   Myeloid and Monocytic Leukemia  P-1187721   \n",
       "434                   Myeloid and Monocytic Leukemia    P-57117   \n",
       "438  Myeloid and Monocytic Leukemia; Leukemia, other    P-46617   \n",
       "455                                         Multiple   P-762420   \n",
       "460                                         Multiple  P-1263921   \n",
       "\n",
       "    Principal_Investigator Date_Opened Date_Closed Study_Phase  \\\n",
       "4       alarcon velasco, s  2020-07-15  2023-02-27          II   \n",
       "10              bambach, b  2018-10-11  2022-04-15         III   \n",
       "11              bambach, b  2016-08-03  2021-06-10         III   \n",
       "30               chatta, g  2019-04-10  2022-12-01          II   \n",
       "31               chatta, g  2019-06-07  2022-07-20        I/II   \n",
       "..                     ...         ...         ...         ...   \n",
       "432                wang, e  2022-05-25  2022-10-25          II   \n",
       "434                wang, e  2018-07-11  2022-09-19           I   \n",
       "438                wang, e  2018-01-10  2022-06-30        I/II   \n",
       "455              zsiros, e  2022-03-17  2022-08-19           I   \n",
       "460              zsiros, e  2022-02-18  2022-12-07           I   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                         Title  \n",
       "4                                                                                                                                                                                                                                          (S1922) A Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma  \n",
       "10                                                                                                                                                       (ACCL1633) The Effectiveness of Lactobacillus plantarum (LBP, IND# 17339) in Preventing Acute Graft-versus-Host Disease (GvHD) in Children undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)  \n",
       "11   (ACCL1333/CV185-155) A Phase III Randomized, Open Label, Multi-center Study of the Safety and Efficacy of Apixaban for Venous Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (T or B cell) Treated with Asparaginase  \n",
       "30                                                                                                                                                                                                   (CITN-14) Randomized Phase II study of Atezolizumab (MPDL3280A) plus Recombinant Human IL-7 (CYT107) in patients with locally advanced or metastatic urothelial carcinoma  \n",
       "31                                                                                                                                                                                                                                          Phase Ib/II Study of Enzalutamide with Venetoclax (ABT-199) in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC)  \n",
       "..                                                                                                                                                                                                                                                                                                                                                                         ...  \n",
       "432                                                                                                                                                                                                                                                                                 A Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients with Myeloid Malignancies  \n",
       "434                                                                                                                                                                    A Phase 1/2, Multi-center, Open-label Study of IMGN632 Monotherapy Administered Intravenously in Patients with CD123-positive Acute Myeloid Leukemia and Other CD123- positive Hematologic Malignancies  \n",
       "438                                                                                                                                                                                                                                                                         Tagraxofusp (SL-401) in Patients with Chronic Myelomonocytic Leukemia (CMML) or Myelofibrosis (MF)  \n",
       "455                                                                                                                                                                  20190131 A Phase 1, Multicenter, Open-label,Dose-Exploration and Dose-Expansion Study Evaluating the Safety,Tolerability,Pharmacokinetics, and Efficacy of AMG 650 in Subjects With Advanced Solid Tumors  \n",
       "460                                                                                                                                                       A Phase 1, multicenter, Open-Label Study of SQZ-AAC-HPV as Monotherapy and in Combination with Immune Checkpoint Inhibitors in HLA-A*02+ Patients with HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors  \n",
       "\n",
       "[105 rows x 7 columns]"
      ]
     },
     "execution_count": 336,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 337,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "105"
      ]
     },
     "execution_count": 337,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials['Protocol'].nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 338,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['II', 'III', 'I/II', 'I', 'IV', 'II/III', 'Early Phase I'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 338,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials['Study_Phase'].unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 339,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_trials['Study_Phase_numeric'] = df_trials['Study_Phase'].replace({'Early Phase I':-1,'I': 1,'I/II':1-2, 'II': 2,'II/III': 2-3, 'III': 3,'IV':4 })"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 340,
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.set_option('display.max_colwidth', None)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 341,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_trials['Code_title'] = df_trials['Title'].str.extract(r'\\((.*?)\\)')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 342,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Primary_Site</th>\n",
       "      <th>Protocol</th>\n",
       "      <th>Principal_Investigator</th>\n",
       "      <th>Date_Opened</th>\n",
       "      <th>Date_Closed</th>\n",
       "      <th>Study_Phase</th>\n",
       "      <th>Title</th>\n",
       "      <th>Study_Phase_numeric</th>\n",
       "      <th>Code_title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Colon</td>\n",
       "      <td>N-626620</td>\n",
       "      <td>alarcon velasco, s</td>\n",
       "      <td>2020-07-15</td>\n",
       "      <td>2023-02-27</td>\n",
       "      <td>II</td>\n",
       "      <td>(S1922) A Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma</td>\n",
       "      <td>2</td>\n",
       "      <td>S1922</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  Primary_Site  Protocol Principal_Investigator Date_Opened Date_Closed  \\\n",
       "4        Colon  N-626620     alarcon velasco, s  2020-07-15  2023-02-27   \n",
       "\n",
       "  Study_Phase  \\\n",
       "4          II   \n",
       "\n",
       "                                                                                                                                 Title  \\\n",
       "4  (S1922) A Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma   \n",
       "\n",
       "   Study_Phase_numeric Code_title  \n",
       "4                    2      S1922  "
      ]
     },
     "execution_count": 342,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials.head(1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 343,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(105, 9)"
      ]
     },
     "execution_count": 343,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 344,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Trial unique -  ['S1922' 'ACCL1633' 'ACCL1333/CV185-155' 'CITN-14' 'ABT-199' 'BPX-601' nan\n",
      " 'ALVR105' 'E4512 ' 'osimertinib' 'CodeBreak 100' 'NSCLC' 'TABAsCO'\n",
      " 'ISN 8951-CL-0301' 'BPX-603' 'HCRN ESO17-325' 'MK-3475' 'ALKS 4230-001'\n",
      " 'HM30181A + Eribulin' 'SC' 'ASG-22CE' 'EBV+' 'A031901' 'ASTX727 LD'\n",
      " 'A091902' 'ABT 199' 'A041702' 'MLN4924, TAK924' 'DLBCL' 'CTLA4-Ig'\n",
      " 'CAR-T' 'AMG 510' 'S1826' 'Pembrolizumab' 'ADT' 'Phase II' 'NRG-GY006'\n",
      " 'A011202' 'NCT03199885' 'NSC #707389' 'CAR' 'AML' 'A021502' 'NCI 9673'\n",
      " 'TAS-102' 'GEC' 'S1827' 'S2000' 'PET-Stop' 'S1609' 'S1801' 'ADCT-301'\n",
      " 'tavo, pIL-12' 'GA-CARES' 'COG ALTE1621' 'BMT CTN Protocol 1507'\n",
      " 'Multi Tumor-Associated Antigen T cells' 'NRG-HN004' 'PAI' 'SBRT' 'S1712'\n",
      " 'AU2' 'VICC HEM1755' 'COG AAML1531' 'COG AALL1521' 'Obi-3424' 'SL-401']\n",
      "\n",
      "Clinical trials =  66\n"
     ]
    }
   ],
   "source": [
    "print('Trial unique - ',df_trials['Code_title'].unique())\n",
    "print()\n",
    "print('Clinical trials = '  ,df_trials['Code_title'].nunique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 345,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'S1922'"
      ]
     },
     "execution_count": 345,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials['Code_title'].value_counts().idxmax()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 346,
   "metadata": {},
   "outputs": [],
   "source": [
    "unique_trials = df_trials['Code_title'].value_counts().sort_values(ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 347,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Code_title\n",
      "S1922                 1\n",
      "MK-3475               1\n",
      "S1826                 1\n",
      "ACCL1333/CV185-155    1\n",
      "CITN-14               1\n",
      "                     ..\n",
      "AU2                   1\n",
      "VICC HEM1755          1\n",
      "COG AAML1531          1\n",
      "COG AALL1521          1\n",
      "SL-401                1\n",
      "Name: count, Length: 66, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "print(unique_trials)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 348,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<pandas._config.config.option_context at 0x2ac4599b290>"
      ]
     },
     "execution_count": 348,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.option_context('display.max_rows', None, 'display.max_columns', None)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 349,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_trials['Study_Duration'] = df_trials['Date_Closed'] - df_trials['Date_Opened']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 350,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Primary_Site</th>\n",
       "      <th>Protocol</th>\n",
       "      <th>Principal_Investigator</th>\n",
       "      <th>Date_Opened</th>\n",
       "      <th>Date_Closed</th>\n",
       "      <th>Study_Phase</th>\n",
       "      <th>Title</th>\n",
       "      <th>Study_Phase_numeric</th>\n",
       "      <th>Code_title</th>\n",
       "      <th>Study_Duration</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Colon</td>\n",
       "      <td>N-626620</td>\n",
       "      <td>alarcon velasco, s</td>\n",
       "      <td>2020-07-15</td>\n",
       "      <td>2023-02-27</td>\n",
       "      <td>II</td>\n",
       "      <td>(S1922) A Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma</td>\n",
       "      <td>2</td>\n",
       "      <td>S1922</td>\n",
       "      <td>957 days</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Other Hematopoietic</td>\n",
       "      <td>N-71918</td>\n",
       "      <td>bambach, b</td>\n",
       "      <td>2018-10-11</td>\n",
       "      <td>2022-04-15</td>\n",
       "      <td>III</td>\n",
       "      <td>(ACCL1633) The Effectiveness of Lactobacillus plantarum (LBP, IND# 17339) in Preventing Acute Graft-versus-Host Disease (GvHD) in Children undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)</td>\n",
       "      <td>3</td>\n",
       "      <td>ACCL1633</td>\n",
       "      <td>1282 days</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Multiple Sites; Leukemia, other</td>\n",
       "      <td>PH-271115</td>\n",
       "      <td>bambach, b</td>\n",
       "      <td>2016-08-03</td>\n",
       "      <td>2021-06-10</td>\n",
       "      <td>III</td>\n",
       "      <td>(ACCL1333/CV185-155) A Phase III Randomized, Open Label, Multi-center Study of the Safety and Efficacy of Apixaban for Venous Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (T or B cell) Treated with Asparaginase</td>\n",
       "      <td>3</td>\n",
       "      <td>ACCL1333/CV185-155</td>\n",
       "      <td>1772 days</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Multiple Sites; Bladder</td>\n",
       "      <td>I-69518</td>\n",
       "      <td>chatta, g</td>\n",
       "      <td>2019-04-10</td>\n",
       "      <td>2022-12-01</td>\n",
       "      <td>II</td>\n",
       "      <td>(CITN-14) Randomized Phase II study of Atezolizumab (MPDL3280A) plus Recombinant Human IL-7 (CYT107) in patients with locally advanced or metastatic urothelial carcinoma</td>\n",
       "      <td>2</td>\n",
       "      <td>CITN-14</td>\n",
       "      <td>1331 days</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Prostate</td>\n",
       "      <td>I-63418</td>\n",
       "      <td>chatta, g</td>\n",
       "      <td>2019-06-07</td>\n",
       "      <td>2022-07-20</td>\n",
       "      <td>I/II</td>\n",
       "      <td>Phase Ib/II Study of Enzalutamide with Venetoclax (ABT-199) in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC)</td>\n",
       "      <td>-1</td>\n",
       "      <td>ABT-199</td>\n",
       "      <td>1139 days</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                       Primary_Site   Protocol Principal_Investigator  \\\n",
       "4                             Colon   N-626620     alarcon velasco, s   \n",
       "10              Other Hematopoietic    N-71918             bambach, b   \n",
       "11  Multiple Sites; Leukemia, other  PH-271115             bambach, b   \n",
       "30          Multiple Sites; Bladder    I-69518              chatta, g   \n",
       "31                         Prostate    I-63418              chatta, g   \n",
       "\n",
       "   Date_Opened Date_Closed Study_Phase  \\\n",
       "4   2020-07-15  2023-02-27          II   \n",
       "10  2018-10-11  2022-04-15         III   \n",
       "11  2016-08-03  2021-06-10         III   \n",
       "30  2019-04-10  2022-12-01          II   \n",
       "31  2019-06-07  2022-07-20        I/II   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                        Title  \\\n",
       "4                                                                                                                                                                                                                                         (S1922) A Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma   \n",
       "10                                                                                                                                                      (ACCL1633) The Effectiveness of Lactobacillus plantarum (LBP, IND# 17339) in Preventing Acute Graft-versus-Host Disease (GvHD) in Children undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)   \n",
       "11  (ACCL1333/CV185-155) A Phase III Randomized, Open Label, Multi-center Study of the Safety and Efficacy of Apixaban for Venous Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (T or B cell) Treated with Asparaginase   \n",
       "30                                                                                                                                                                                                  (CITN-14) Randomized Phase II study of Atezolizumab (MPDL3280A) plus Recombinant Human IL-7 (CYT107) in patients with locally advanced or metastatic urothelial carcinoma   \n",
       "31                                                                                                                                                                                                                                         Phase Ib/II Study of Enzalutamide with Venetoclax (ABT-199) in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC)   \n",
       "\n",
       "    Study_Phase_numeric          Code_title Study_Duration  \n",
       "4                     2               S1922       957 days  \n",
       "10                    3            ACCL1633      1282 days  \n",
       "11                    3  ACCL1333/CV185-155      1772 days  \n",
       "30                    2             CITN-14      1331 days  \n",
       "31                   -1             ABT-199      1139 days  "
      ]
     },
     "execution_count": 350,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 351,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "39"
      ]
     },
     "execution_count": 351,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials['Primary_Site'].nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 352,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_trials.to_csv('Trials.csv', index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 353,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Primary_Site</th>\n",
       "      <th>Protocol</th>\n",
       "      <th>Principal_Investigator</th>\n",
       "      <th>Date_Opened</th>\n",
       "      <th>Date_Closed</th>\n",
       "      <th>Study_Phase</th>\n",
       "      <th>Title</th>\n",
       "      <th>Study_Phase_numeric</th>\n",
       "      <th>Code_title</th>\n",
       "      <th>Study_Duration</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Colon</td>\n",
       "      <td>N-626620</td>\n",
       "      <td>alarcon velasco, s</td>\n",
       "      <td>2020-07-15</td>\n",
       "      <td>2023-02-27</td>\n",
       "      <td>II</td>\n",
       "      <td>(S1922) A Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma</td>\n",
       "      <td>2</td>\n",
       "      <td>S1922</td>\n",
       "      <td>957 days</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Other Hematopoietic</td>\n",
       "      <td>N-71918</td>\n",
       "      <td>bambach, b</td>\n",
       "      <td>2018-10-11</td>\n",
       "      <td>2022-04-15</td>\n",
       "      <td>III</td>\n",
       "      <td>(ACCL1633) The Effectiveness of Lactobacillus plantarum (LBP, IND# 17339) in Preventing Acute Graft-versus-Host Disease (GvHD) in Children undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)</td>\n",
       "      <td>3</td>\n",
       "      <td>ACCL1633</td>\n",
       "      <td>1282 days</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Multiple Sites; Leukemia, other</td>\n",
       "      <td>PH-271115</td>\n",
       "      <td>bambach, b</td>\n",
       "      <td>2016-08-03</td>\n",
       "      <td>2021-06-10</td>\n",
       "      <td>III</td>\n",
       "      <td>(ACCL1333/CV185-155) A Phase III Randomized, Open Label, Multi-center Study of the Safety and Efficacy of Apixaban for Venous Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (T or B cell) Treated with Asparaginase</td>\n",
       "      <td>3</td>\n",
       "      <td>ACCL1333/CV185-155</td>\n",
       "      <td>1772 days</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Multiple Sites; Bladder</td>\n",
       "      <td>I-69518</td>\n",
       "      <td>chatta, g</td>\n",
       "      <td>2019-04-10</td>\n",
       "      <td>2022-12-01</td>\n",
       "      <td>II</td>\n",
       "      <td>(CITN-14) Randomized Phase II study of Atezolizumab (MPDL3280A) plus Recombinant Human IL-7 (CYT107) in patients with locally advanced or metastatic urothelial carcinoma</td>\n",
       "      <td>2</td>\n",
       "      <td>CITN-14</td>\n",
       "      <td>1331 days</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Prostate</td>\n",
       "      <td>I-63418</td>\n",
       "      <td>chatta, g</td>\n",
       "      <td>2019-06-07</td>\n",
       "      <td>2022-07-20</td>\n",
       "      <td>I/II</td>\n",
       "      <td>Phase Ib/II Study of Enzalutamide with Venetoclax (ABT-199) in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC)</td>\n",
       "      <td>-1</td>\n",
       "      <td>ABT-199</td>\n",
       "      <td>1139 days</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                       Primary_Site   Protocol Principal_Investigator  \\\n",
       "4                             Colon   N-626620     alarcon velasco, s   \n",
       "10              Other Hematopoietic    N-71918             bambach, b   \n",
       "11  Multiple Sites; Leukemia, other  PH-271115             bambach, b   \n",
       "30          Multiple Sites; Bladder    I-69518              chatta, g   \n",
       "31                         Prostate    I-63418              chatta, g   \n",
       "\n",
       "   Date_Opened Date_Closed Study_Phase  \\\n",
       "4   2020-07-15  2023-02-27          II   \n",
       "10  2018-10-11  2022-04-15         III   \n",
       "11  2016-08-03  2021-06-10         III   \n",
       "30  2019-04-10  2022-12-01          II   \n",
       "31  2019-06-07  2022-07-20        I/II   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                        Title  \\\n",
       "4                                                                                                                                                                                                                                         (S1922) A Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma   \n",
       "10                                                                                                                                                      (ACCL1633) The Effectiveness of Lactobacillus plantarum (LBP, IND# 17339) in Preventing Acute Graft-versus-Host Disease (GvHD) in Children undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)   \n",
       "11  (ACCL1333/CV185-155) A Phase III Randomized, Open Label, Multi-center Study of the Safety and Efficacy of Apixaban for Venous Thromboembolism Prevention versus No Systemic Anticoagulant Prophylaxis during Induction Chemotherapy in Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (T or B cell) Treated with Asparaginase   \n",
       "30                                                                                                                                                                                                  (CITN-14) Randomized Phase II study of Atezolizumab (MPDL3280A) plus Recombinant Human IL-7 (CYT107) in patients with locally advanced or metastatic urothelial carcinoma   \n",
       "31                                                                                                                                                                                                                                         Phase Ib/II Study of Enzalutamide with Venetoclax (ABT-199) in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC)   \n",
       "\n",
       "    Study_Phase_numeric          Code_title Study_Duration  \n",
       "4                     2               S1922       957 days  \n",
       "10                    3            ACCL1633      1282 days  \n",
       "11                    3  ACCL1333/CV185-155      1772 days  \n",
       "30                    2             CITN-14      1331 days  \n",
       "31                   -1             ABT-199      1139 days  "
      ]
     },
     "execution_count": 353,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 357,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Timestamp('2014-04-08 00:00:00')"
      ]
     },
     "execution_count": 357,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_trials['Date_Opened'].min()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "df_trials['Study_Duration'] = pd.to_timedelta(df_trials['Study_Duration'])\n",
    "\n",
    "df_trials['Study_Duration_days'] = df_trials['Study_Duration'].dt.days\n",
    "\n",
    "plt.figure(figsize=(10, 6))\n",
    "sns.boxplot(x='Study_Phase_numeric', y='Study_Duration_days', data=df_trials)\n",
    "plt.title('Relación entre la fase del estudio y la duración del estudio')\n",
    "plt.xlabel('Fase del estudio')\n",
    "plt.ylabel('Duración del estudio (días)')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x1000 with 5 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Asegúrate de que 'Study_Duration' sea de tipo 'timedelta'\n",
    "df_trials['Study_Duration'] = pd.to_timedelta(df_trials['Study_Duration'])\n",
    "\n",
    "# Convierte 'Study_Duration' a días\n",
    "df_trials['Study_Duration_days'] = df_trials['Study_Duration'].dt.days\n",
    "\n",
    "# Crea una figura y un conjunto de subtramas con un tamaño más grande en el eje y\n",
    "fig, axs = plt.subplots(nrows=df_trials['Study_Phase_numeric'].nunique(), figsize=(10, 10))\n",
    "\n",
    "# Para cada fase del estudio, crea un histograma o un gráfico KDE\n",
    "for i, phase in enumerate(df_trials['Study_Phase_numeric'].unique()):\n",
    "    sns.histplot(data=df_trials[df_trials['Study_Phase_numeric'] == phase], x='Study_Duration_days', kde=True, ax=axs[i])\n",
    "    axs[i].set_title(f'Fase del estudio: {phase}')\n",
    "    axs[i].set_xlabel('Duración del estudio (días)')\n",
    "\n",
    "plt.tight_layout()\n",
    "plt.show()\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.1"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
